Literature DB >> 16497603

Precessation treatment with nicotine skin patch facilitates smoking cessation.

Jed E Rose1, Frederique M Behm, Eric C Westman, Prity Kukovich.   

Abstract

Nicotine replacement therapy (NRT) is a well-established treatment to aid smoking cessation, and current products recommend using NRT only after quitting smoking. However, theoretical arguments and previous data support the hypothesis that precessation use of NRT might be useful in reducing dependence on inhaled nicotine and serve as a helpful prelude to smoking cessation. The present study explored the use of NRT for 2 weeks before a target quit-smoking date, during which subjects continued to smoke ad libitum. Three experimental conditions varied the nicotine delivery of the cigarettes smoked during these 2 weeks so that we could examine the effects of concurrent nicotine administration on compensatory smoking of low tar and nicotine cigarettes. Subjects smoked (a) their usual brands of cigarettes, (b) conventional low tar and nicotine cigarettes, or (c) denicotinized cigarettes. After the quit date, subjects received pharmacotherapy consisting of various doses of NRT (0, 21, or 42 mg/24-hr) in combination with the nicotinic antagonist mecamylamine (10 mg/day). Results showed that precessation nicotine patch treatment was associated with a significantly higher rate of continuous smoking abstinence at 4 weeks, regardless of cigarette condition. Ad libitum smoking before the target quit date was modulated by nicotine patch treatment, and compensatory increases in smoking low tar and nicotine cigarettes were prevented by concurrent use of nicotine patches. These results suggest that use of NRT before a target quit-smoking date deserves further evaluation as a possible smoking cessation treatment. Moreover, while nicotine patches were well tolerated when subjects smoked nicotine-containing cigarettes, the use of nicotine skin patches with reduced-nicotine cigarettes potentially offers the advantage of increased efficacy without introducing concern about toxic effects of excessive nicotine intake.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497603     DOI: 10.1080/14622200500431866

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  49 in total

1.  Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats.

Authors:  Edward D Levin; Joshua E Johnson; Susan Slade; Corinne Wells; Marty Cauley; Ann Petro; Jed E Rose
Journal:  J Pharmacol Exp Ther       Date:  2011-06-02       Impact factor: 4.030

2.  Precipitated withdrawal from nicotine reduces reinforcing effects of a visual stimulus for rats.

Authors:  Matthew T Weaver; Maggie Sweitzer; Sarah Coddington; Jaimee Sheppard; Nicole Verdecchia; Anthony R Caggiula; Alan F Sved; Eric C Donny
Journal:  Nicotine Tob Res       Date:  2012-01-04       Impact factor: 4.244

Review 3.  New methods for tobacco dependence treatment research.

Authors:  Timothy B Baker; Robin Mermelstein; Linda M Collins; Megan E Piper; Douglas E Jorenby; Stevens S Smith; Bruce A Christiansen; Tanya R Schlam; Jessica W Cook; Michael C Fiore
Journal:  Ann Behav Med       Date:  2011-04

4.  Socioeconomic position and abrupt versus gradual method of quitting smoking: findings from the International Tobacco Control Four-Country Survey.

Authors:  Mohammad Siahpush; Hua-Hie Yong; Ron Borland; Jessica L Reid
Journal:  Nicotine Tob Res       Date:  2010-10       Impact factor: 4.244

5.  The early time course of smoking withdrawal effects.

Authors:  Peter S Hendricks; Joseph W Ditre; David J Drobes; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

Review 6.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

Review 7.  Nicotine and nonnicotine factors in cigarette addiction.

Authors:  Jed E Rose
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

8.  Stimulus and Response Expectancies Influence the Cognitive Effects of Cigarettes.

Authors:  William L Kelemen
Journal:  J Smok Cessat       Date:  2008

9.  Scientific overview: 2013 BBC plenary symposium on tobacco addiction.

Authors:  M De Biasi; I McLaughlin; E E Perez; P A Crooks; L P Dwoskin; M T Bardo; P R Pentel; D Hatsukami
Journal:  Drug Alcohol Depend       Date:  2014-06-02       Impact factor: 4.492

10.  Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.

Authors:  Eric C Donny; Melissa Jones
Journal:  Drug Alcohol Depend       Date:  2009-05-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.